Subscribe or Manage Preferences

Urology Practice Management - June 2015, Vol 4, No 3

Severe urinary hesitancy may be associated with increased risk of bladder cancer, according to data analysis of more than 30,000 men. Researchers suggest that voiding dysfunction leads to extended contact time between potential carcinogens and the cells lining the bladder.
Early use of docetaxel in some men with castration-resistant prostate cancer was associated with a 17-month improvement in survival, according to new data supporting the updated NCCN guideline.
Two pilot programs that bridge health plans and health systems showed success in raising awareness of inappropriate testosterone replacement therapy in men with age-related hypogonadism.
n analysis using the IMS LifeLink Health Plan Claims Database has shown that patients who undergo minimally invasive robotic-assisted radical prostatectomy experience a shorter hospital length of stay and somewhat better postoperative outcomes than patients who undergo open radical prostatectomy, albeit with a higher price tag, according to a study that was published recently in Prostate Cancer and Prostatic Disease.
Significant cost-savings in treating patients with prostate cancer could be achieved in the US healthcare system with the use of the cell-cycle progression (CCP) gene-expression assay called Prolaris.
A new analysis suggests that adherence to guidelines for follow-up care in patients who have undergone a radical cystectomy may standardize care but may also increase expenditures compared with the cost of most current approaches, which are more conservative and deviate from existing guidelines.
Patients with urologic cancer who are readmitted after a surgery to a second hospital and not to their original hospital are more likely to have complications than patients readmitted to their original surgical hospital, according to findings presented at the 2015 Genitourinary Cancers Symposium.
Criteria for stage 3 of Meaningful Use was announced and published recently, detailing benchmarks that eligible providers and hospitals will have to meet to qualify for certain incentive payments and avoid reimbursement penalties.
The April 14, 2015, repeal of the sustainable growth rate (SGR) formula for physician payments under Medicare is being welcomed by the healthcare community, including the American Society of Clinical Oncology (ASCO).
As a physician with substantial income (or income potential), you will most likely be contacted by a number of individuals offering various types of financial products and services throughout your career.
Page 1 of 2
Results 1 - 10 of 11
  • American Health and Drug Benefits
  • Association for Value Based Cancer Care
  • Lynx CME
  • Oncology Practice Management
  • Rheumatology Practice Management

Search